Assuming that most MCI patients, especially patients with amnestic MCI [8], have an underlying pathology of AD, it is logical to investigate whether drug treatment strategies for AD might be effective in the treatment of MCI (e.g. treatment with acetylcholinesterase inhibitors (AChEI) or ginkgo biloba). The gene discussed is ACHE; the disease is Alzheimer disease.